Literature DB >> 24564845

Polymorphism of costimulatory molecules (CTLA4, ICOS, PD.1 and CD28) and allogeneic hematopoietic stem cell transplantation in Iranian patients.

Mahdiyar Iravani-Saadi1, Mohammad Hossein Karimi, Ramin Yaghobi, Bita Geramizadeh, Mani Ramzi, Ahmad Niknam, Arefeh Pourfathollah.   

Abstract

Costimulatory molecules are important factors determining the outcome of bone marrow transplant. Because the host ability in costimulatory molecule function may be affected by gene polymorphisms, the aim of the present study was to investigate the effect of CTLA4, ICOS, PD.1 and CD28 gene polymorphisms in outcome of bone marrow transplant patients. A total of 72 recipients were included in this study. CTLA4 (-1722, -1661, -318, +49), ICOS (+1720), CD28 (+17) and PD.1 (PD.1.3, PD.1.9) gene polymorphisms were evaluated by PCR-RFLP. The results showed that no differences in the distribution of all mentioned costimulatory molecules genotypes and alleles were observed in the Graft Versus Host Disease (GVHD) group compared to the non-GVHD group. After gender classification, there is a significant association between GA genotype (CTLA4-1661) in male group with GVHD than without GVHD (p=0.03). Also, in this study we found significant associations between CC genotype and C allele of PD.1.9, and TT genotype and T allele of CD28 that had more frequency in grades 2-4 (p=0.04. p=0.02, p=0.01, p=0.003, respectively). Results indicate that the CC genotype and C allele of PD.1.9 and TT genotype and the T allele of CD28 are genetic risk factors for development of a severe grade of GVHD. This subject needs to be studied in different population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24564845     DOI: 10.3109/08820139.2013.879594

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  6 in total

1.  Polymorphisms of co-inhibitory molecules (CTLA-4/PD-1/PD-L1) and the risk of non-small cell lung cancer in a Chinese population.

Authors:  Yuan Ma; Xiuchun Liu; Jingyan Zhu; Wanhu Li; Liangjun Guo; Xiao Han; Bao Song; Sensen Cheng; Liu Jie
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Lidia Karabon; Miroslaw Markiewicz; Anna Partyka; Edyta Pawlak-Adamska; Anna Tomkiewicz; Monika Dzierzak-Mietla; Slawomira Kyrcz-Krzemien; Irena Frydecka
Journal:  Immunogenetics       Date:  2015-05-05       Impact factor: 2.846

3.  Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Graft-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model.

Authors:  Aude Burlion; Simon Brunel; Nicolas Y Petit; Daniel Olive; Gilles Marodon
Journal:  Front Immunol       Date:  2017-06-30       Impact factor: 7.561

Review 4.  Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes.

Authors:  Rihab Gam; Pranali Shah; Rachel E Crossland; Jean Norden; Anne M Dickinson; Ralf Dressel
Journal:  Front Immunol       Date:  2017-04-03       Impact factor: 7.561

5.  Association of IL-12 and TNF-α Polymorphisms with Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Authors:  M H Karimi; S Salek; R Yaghobi; M Ramzi; B Geramizadeh; F Kafilzadeh
Journal:  Int J Organ Transplant Med       Date:  2019-02-01

6.  Association of CTLA4 Gene Polymorphism with Transfusion Reaction after Infusion of Leukoreduced Blood Component.

Authors:  Ying-Hao Wen; Wei-Tzu Lin; Wei-Ting Wang; Tzong-Shi Chiueh; Ding-Ping Chen
Journal:  J Clin Med       Date:  2019-11-13       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.